Announcements Trials

Browse Landscape

Phase

Phase 1/2 1 Phase 1 1

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Melanoma 1 Breast Neoplasms 1

Interventions

Trastuzumab 62 Paclitaxel 57 Cyclophosphamide 44 pembrolizumab 34 Fulvestrant 34 Capecitabine 29 Carboplatin 26 Docetaxel 23 Letrozole 22 Doxorubicin 19 palbociclib 16 abemaciclib 16 pertuzumab 15 durvalumab 14 Filgrastim 13 Everolimus 13 ribociclib 12 Lapatinib 12 Gemcitabine 12 exemestane 11 eribulin 11 Vinorelbine 11 Albumin-Bound Paclitaxel 11 Bevacizumab 10 trastuzumab deruxtecan 9 neratinib 9 fludarabine 9 Taxes 9 Radiotherapy 9 Peripheral Blood Stem Cell Transplantation 9

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Breast Neoplasms × Fecal Microbiota Transplantation × Clear all

NCT07292142 2025-12-18

FRIDA

Jewish General Hospital

Phase 1/2 Not yet recruiting

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡